Introduction:Approximately one third of the world's population has serological evidence of past or present infection with the hepatitis B virus (HBV). An estimated 350-400 million people are surface HBV antigen (HBsAg) carriers. Thus, HBV infection is one of the most important infectious diseases worldwide. India is facing major burnt of this deadly disease and has 40 million HBV carriers i.e., 10-15% share of total pool of HBV carriers of the world. In India, 100,000 patients die due to HBV infection.
Aims and Objectives:To determine epidemiological profile, clinical presentation, risk factors, co-infection, use of alternative medications, need and compliance on antiviral treatment in patients of Hepatitis B virus infection.
Materials & Methods:This retrospective study was done at Post Graduate Institute of Medical Sciences, Rohtak over a period of ten years i.e., 01.09.2010 to 31.08.2020, on all HbsAg positive patients who reported for consultation and treatment on outdoor basis i.e., on OPD basis who were not admitted or were admitted in indoor wards of hospital. In our study total 4850 patients were identified but 22 patients refused to get enrolled in the study, hence total 4828 patients were finally enrolled and their records were collected regarding their detailed epidemiological profile and clinical spectrum. In accordance with estimated prevalence of Hepatitis B in Haryana, sample size was calculated. At inclusion time, detailed history of the patient was recorded, clinical examination and detailed investigations were done Conclusion: Hepatitis B is a major health issue in India with non-uniform distribution and certain geographical areas are hotspots like Haryana. The young males belonging to rural background are most vulnerable due to lack of safe injection practices and proper health care facilities. Majority of patients of Chronic hepatitis B are in inactive stage, thus not requiring treatment but on regular follow up. Only 10% of patients presented with acute hepatitis B. The history of use of parenteral injections, surgical interventions and dental procedures has been found to be important risk factor. We cannot rely on blood bank data for determining the prevalence of it but screening of high-risk population in at least hotspots will reflect true picture. Moreover, it will lead to early detection of cases and thus will substantially decrease the development of long-term complications like cirrhosis and hepatocellular carcinoma, as shown in our this study.